Open access · CC-BY
via OpenAlex
LEVERAGING THE NDUFS4-/- MOUSE AS A PLATFORM FOR TESTING LONGEVITY INTERVENTIONS
Alessandro Bitto, Cara Tobey, Ayush Sharma, Anthony S. Grillo, Matt R. Kaeberlein
Innovation in Aging · 2022
Abstract
Abstract Mitochondrial dysfunction(definition) is one of the hallmarks of biological aging, as well as the driving factor for mitochondrial diseases. Up to 30% of mitochondrial disorders are due to mutations affecting the activity of Complex I in the electron transport chain. Loss of the Complex I subunit Ndufs4 recapitulates symptoms of Leigh Syndrome, a pediatric mitochondrial disease, in mouse. Ndufs4-/- mice suffer developmental delays, early onset of neurological symptoms and extremely reduced lifespan. Several studies have now shown that Ndufs4-/- mice are exquisitely responsive to treatments and interventions of interest in the biology of aging, such as mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), NAD+ precursors, reduced oxygen tension, alpha-keto-glutarate precursors, and the antidiabetic drug acarbose. These results point to common mechanisms underlying both aging and mitochondrial disorders. To put this hypothesis to the test, we show that Ndufs4-/- mice are responsive to a wide range of longevity interventions previously tested in worms, mice, and by the National Institute on Aging’s Intervention Testing Program. These observations support the hypothesis that mitochondrial and metabolic dysfunction induced by Complex I deficiency may be a key component of biological aging as well as mitochondrial disease. Furthermore, we propose that the Ndufs4-/- mice provide an affordable testing ground for candidate longevity interventions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/geroni/igac059.2663
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Bitto, A., Tobey, C., Sharma, A., Grillo, A.S., & Kaeberlein, M.R. (2022). LEVERAGING THE NDUFS4-/- MOUSE AS A PLATFORM FOR TESTING LONGEVITY INTERVENTIONS. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igac059.2663
Vancouver
Bitto A, Tobey C, Sharma A, Grillo AS, Kaeberlein MR. LEVERAGING THE NDUFS4-/- MOUSE AS A PLATFORM FOR TESTING LONGEVITY INTERVENTIONS. Innovation in Aging. 2022. doi:10.1093/geroni/igac059.2663.
BibTeX
@article{alessandro2022LEVERA,
title = {LEVERAGING THE NDUFS4-/- MOUSE AS A PLATFORM FOR TESTING LONGEVITY INTERVENTIONS},
author = {Alessandro Bitto and Cara Tobey and Ayush Sharma and Anthony S. Grillo and Matt R. Kaeberlein},
journal = {Innovation in Aging},
year = {2022},
doi = {10.1093/geroni/igac059.2663},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY
Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh Syndrome
Innovation in Aging 2020
Open access · CC-BY
Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh Syndrome
Experimental Gerontology 2014
Preprint · OA
The paradox of mitochondrial dysfunction and extended longevity
Scientific Reports 2019
Open access · CC-BY
Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease
2025
Open access · CC-BY
Targeting Longevity: Supplements as Interventions to Modulate Aging Pathways and Enhance Healthspan
Aging 2012
Preprint · CC-BY